In many types of cancers, PD-1 is highly expressed in tumour-infiltrating lymphocytes (TILs), including both CD4+ and CD8+ T cells, and the upregulated protein expression is correlated with tumour size and worse overall survival of cancer patients [11,12]. This evidence concerns the gene CD8A and cancer.